BABCOCK+WILCOX ENT.DL-,01

Babcock & Wilcox reported adjusted EPS of $0.07 for Q2 2026 (expectation $0.03) and revenue of $319.7 million versus consolidated $196.97 million, an increase of 130% year‑over‑year. Net income climbed to $14.3 million after a net loss of $58.5 million in the year‑ago quarter. Management raised the full‑year adjusted EBITDA guidance to $80–105 million, announced a $50 million share buyback program and the repayment of outstanding 6.50% notes ($61.4 million), and pointed to a project pipeline of over $14 billion. The stock jumped about 40.5% in premarket trading to $12.48. » Więcej na de.investing.com

The board of directors of Babcock & Wilcox has approved a share buyback program of up to $50 million, to begin after filing the Form 10-Q for Q2 2026. Repurchases may be made in the open market, through private transactions, block trades or under Rule 10b5-1/10b-18; the program does not obligate any purchases, has no fixed expiration date and can be suspended. CEO Kenneth Young described the move as an expression of confidence in the balance sheet and as opportunistic capital allocation alongside growth investments. The stock traded at $11.70; analysts quoted by InvestingPro currently see it above fair value but maintain price targets between $23 and $26 and forecast profitability and earnings growth. » Więcej na de.investing.com

The stock of Babcock & Wilcox fell about 12.6% in premarket trading after the company placed 10,810,811 common shares at $18.50 per share, raising roughly $200 million gross. The underwriters were granted a 30-day option to place up to an additional 15% of the shares; closing is expected on May 18, 2026. Net proceeds are to be used to prepay and then reestablish credit facilities, to expand steam turbine and boiler capacity, to finance AI data-center projects, to commercialize the BrightLoop technology, and for possible acquisitions and general corporate purposes. » Więcej na de.investing.com